Member Info for Pingu777

I only. Prices the 9.25 this morning from Zacs! Sorry about that. 8.3 holding strong here which is positive. And the buys are pouring in.

Lowish volume, walked down by MMs. Lots of PI small sells ensue as they worry and the MMs accumulate more cheap shares. Hopefully the buying returns at these excellent entry points!

Just so people are fully aware, the buying action released after hours yesterday were in the vast majority buys. Look at the timing and the price and the buy and sell prices at the time.

Plenty of interest here in the news to come. Vox very confident about hemo and Zaks bullish level of 9p was held yesterday. Short term SP target of 20p in his chart. Plenty of value here and that’s irrespective of the news flow to come.

Orgenesis are continuing to grow their POC network. This network will develop drugs on site for hospitals saving them time and money. I expect them to be using our mice to develop these treatments and also be delivering HuPech and possibly Car T.

It’s a great area of distribution for us over the coming year or two.

Not many selling today I’d imagine. A real rookie move if you are. The SP so easy to manipulate on lower volumes.

We don’t have a formal partner for HEMO Car T Officially yet. Eli fav to take it forward once ready for FDA approval for human trial. Next month or 2

https://www.lilly.com/partners/scientific-partnering-areas-of-interest

Have a look what Eli are openly seeking for partnerships. Numerous boxes we tick on there relating to
-immunotherapy
-oncology
-platform discovery

Read the points under these headings. They’ll be falling over themselves.

Investing in hemo was always simply about patience.

Very soon it’s going to be more about patients ;-)

Nice to look back at your research sometimes...

GlobalCo - who is it? My view is...04 Jun 2020 16:22

A company announced on 1 June that they had speeded through their pre-clinical trials at record pace to successfully proceed with a neutralising antibody treatment for COVID-19. Not only did they become the first company to get to this stage on any similar types of treatment they actually joined the party late beginning their work later than anyone else.

What is one of our specialities? Identifying and isolating neuatralising antibodies. Like CDX. What do we have that helps us do this so efficiently and ridiculously quickly as confirmed by Vered Caplan at Orgenesis when she confirmed our mice can help reduce antibody development from years to months? Our ApbHC magic mice.

So two key features we see demonstrated by a leading GlobalCo in their 1 June announcement linking potentially to HEMO are:
- neutralising antibody treatment for COVID 19
- breakneck speed in working through and completing pre-clinical trials

Now, what do GlobalCo have access to in our collab? We have 2 specific agreements with them with the most recent beginning on 23 October 2019. Specifically CDX tech (a bi-specific neutralising antibody) as we all know AND more importantly for me... our revolutionary mice.

There is only one way said company could have got through the pre-clinicals as fast as they have - imo - because they're using our advanced mice. Better than any other animal testing out there for antibody work in particular and disease modelling.

That 1 June announcement was from Eli Lilly. $144b company. Please DYOR.

Thought everyone new this?

Time for an afternoon RNS please! Come on HEMO, blow the doors off.

Seriously though our NASDAQ GlobalCo partner will be controlling the news release. When will they prefer it to go out?

Which if you’re a boring negative guts is going to be here when it pops? Bet you’re quiet.
So tired the dog won’t sit with me.

Deadline for Qs my old mucker.

But 3 month extension drops end of July mate. Either we have the Q&A and then the stuff people want to know comes after within 10/11 days. Or they announce next week and do a Q&A to really thrash out the points of the deal and celebrate the new info? Surely RNS next week.

PMA. Positive mental attitude

The question is... will there be an RNS next week to talk about in the Q&A or will there not?

My opinion is that if I was Vlad - then yes. I’m not doing a Q&A whilst people are demanding GlobalCo name and deals.

If only we had some big buys coming in Dr Anomaly???

Be interesting to see the after hours...

You make your own mind up swimming

Defendant
HemoGenix, Inc.

Plaintiff
Hemogenyx LLC
Represented By
Robert Phillip Feinland
Meister Seelig & Fein LLP
contact info
Marc P. Misthal
Gottlieb, Rackman & Reisman
contact info

Plaintiff
Hemogenyx Pharmaceuticals plc
Represented By
Robert Phillip Feinland
Meister Seelig & Fein LLP
contact info
Marc P. Misthal
Gottlieb, Rackman & Reisman
contact info

Complaint withdrawn 8 July.

Sorted privately and we keep use of the name and use for naming patents.

Swimming haha

It lost its legal case and then changed its name to the one it wouldn’t be allowed to use?

Getting their house in order me thinks.

Has Hemogenyx carried out an impact study of the mice on the drug development process from start to finish? Hemo's ApbHC allow for more rigorous testing of the toxicity and dosage during the pre-clinical stages which helps expedite the clinical trials in phase 1 and phase 2 as we know more before the human testing. But by how much? And what other areas of testing can be speeded up due to the nature of our mice?

If we have made estimations at these sort of numbers then we need to release this information to market so investors can fully grasp the potential of just one of hemogenyx amazing assets. In my opinion the magnitude and value of the mice is vastly underestimated. Eli Lilly suggest their average cost for the process is $1b and average timescale is 10yrs. Can we half this using our mice?

Correction not Japan, China.